Development and manufacturing of medicines

    From lab to market, faster and with lower risk

    Request information with no obligation

    Fill in the following form and someone from TECNALIA will get back to you as soon as possible.

    Technology, digitalisation, sensors, and a better quality of life

    New pharmaceutical technologies, digitalisation, and process automation will enable us to optimise drug development and manufacturing projects for our customers and partners.

    At TECNALIA, we aim to position ourselves among the top three national players in the field of pharmaceutical development and drug manufacturing in terms of contract volume. Also, to be among the top 10 European CDMOs, recognised for technical versatility and positioning in specific and leading pharmaceutical development areas.

    To this end, we apply new pharmaceutical technologies, such as 3D printing, new administration routes, new pharmaceutical forms. Above all, we contribute to digitalisation, process automation, and sensor features applied to process development, manufacturing, and control.  

    The combination of experience, quality systems, and equipment enables us to offer high-quality and customised solutions to the pharmaceutical industry, adapting to their specific needs. This way, we tackle complex challenges with confidence and efficiency.

    Every innovation we bring to the pharmaceutical industry has an impact on society: better and more effective medicines, more optimal treatments, better prevention, and a better quality of life for patients.

    We ensure that we keep up to date with the latest technologies and methodologies in the industry, improving our clients' projects and their products, especially in four differential impacts: 

    • Economic impact
    • Social impact
    • Public-Private Partnership impact
    • Impact on the growth of the Pharmaceutical Node of the Basque Country.

    There are four main blocks for expansion, growth, and innovation in the pharmaceutical sector:

    • Advanced formulations. Drug combinations, 3D printing, innovative formulations, growth of biologics, etc.
    • New analytical technologies. Non-invasive techniques, new technologies applied to biological products such as the microbiome, gene sequencing, and more.
    • Innovation and digitalisation of industrial processes such as automation or advanced industrialisation, expansion of industrial capacities, etc.
    • Creation and expansion of collaborative networks between public and private sectors, basic and applied research, and talent generation, which will remain part of the sector’s future.  

    Downloadable information on the development and manufacture of medicines

    Download the document by filling in the following form

    Request information with no obligation

    Fill in the following form and someone from TECNALIA will get back to you as soon as possible.